Risk Factors for Cardiac Mortality in Cases of Syncope with Previous History of Myocardial Infarction;Facteurs de Risque de Mortalité Cardiaque en cas de Syncope et d'Antécédents d'Infarctus du Myocarde

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue 12, 2003, Pages 1181-1186

  Brembilla Perrot, B ^a   Suty Selton, C ^c   Alla, F ^b   Beurrier, D ^a   Houriez, P ^a   Claudon, O ^a   Terrier De La Chaise, A ^a   Louis, P ^a   Sadoul, N ^a   Andronache, M ^a   Miltjoen, H ^a   Juilliere Y ^a  

^a CHU NANCY BRABOIS   (France)

^b Epidemiol et Evaluations Cliniques   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HEART STIMULATION; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE; VAGUS TONE;

ADULT; AGED; AGED, 80 AND OVER; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SYNCOPE;

EID: 12144291513     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Middlelkauf HR, Stevenson WG, Saxon LA. Prognosis after syncope: impact of left ventricular function. Am Heart J 1993; 125: 121-7.
2. Savage DD, Corwin L, Mc Gee D, Kannel W, Wolff P. Epidemiologic features of isolated syncope. The Framingham Study. Stroke 1985; 16: 626-9.
3. Kapoor W, Karpf M, Wieand S, Peterson J, Levey GA. Prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983; 309: 197-204.
4. Krol R, Morady F, Flaker C et al. Electrophysiologic testing in patients with unexplained syncope: clinical and noninvasive predictors of outcome. J Am Coll Cardiol 1987; 10: 358-63.
5. Olshansky B, Mazuz M, Marfins JB. Significance of inducible tachycardia in patients with syncope of unknown origin. J Am Coll Cardial 1985; 5: 216-23.
6. Kapoor WN. Current evaluation and management of syncape. Circulation 2002; 106: 1606-9.
7. Menozzi C, Brignole M, Garcia-Civera R et al., on behalf of the International Study on Syncope on of Uncertain Etiology. (ISSUE) Investigators. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 2002, 105: 2741-5.
8. Blanc JJ. La syncope vasovagale, du diagnostic au traitement. Arch Mal Cœur 1994; 87 (1): 47-53.
9. Brembilla-Perrot B. La stimulation ventriculaire prorammée dans les syncopes inexpliquées. Facteurs de risque de déclenchement d'une tachycardie ventriculaire. Arch Mal Cœur 1991; 84: 1425-30.
10. Ellison KE, Hafley GE, Hickey K et al., for the MUSTT Investigators. Effect of β-blocking therapy on outcome in the Multicenter Unsustained Tachycardia Trial (MUSTT). Circulation 2002; 106: 2694-9.
11. Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN. Implantable defibrillator event rotes in patients with unexplained syncope and inducible ventricular tachyarrhythmias. A comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardial 1999; 34: 2023-30.
12. Breithardt G, Borggrefe M, Hierten K. Ventricular late potentials and inducible ventricular tachyarrhythmias as a marker for ventricular tachycardia after myocardial infarction. Eur Heart J 1986; 7 (Suppl. A): 127-34.
13. Denniss AR, Richards DA, Cody DV et al. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiogram of survivors of acute myocardial infarction. Circulation 1986; 1074: 737-45.
14. Brembilla-Perrot B, Terrier de la Chaise A, Briancon S et al. Programmed ventricular stimulation in survivors of acute infarction: long term follow-up. Int J Cardiol 1995; 49: 55-65.
15. Moss AJ, Zareba W, Hall J et al., for the Multicenter Automatic Defibrillator Implantation Triat II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
16. Middlekauff HR, Stevenson WG, Warner Stevenson L, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993; 21: 110-6.
17. Andrews NP, Fogel RJ, Pelargonio G, Evans JJ, Prystowsky EN. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1999; 34: 2023-30.
18. Mont L, Valentino M, Sambola A, Matas M, Aquinaga L, Brugada J. Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation. J Am Coll Cardial 999; 34: 3-51-7.
19. BuxtonA E, Lee KL, Hafley GE et al., for the MUSTT investigators. Relation of ejectian fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease. An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial. Circulation 2002; 106: 2466-72.
20. Claudon O, Brembilla-Perrot B, Jacquemin L et al. Suivi à long terme de 115 patients atteints de cardiopathie ischémique avec flutter ventriculaire déclenché lors d'une stimulation ventriculaire programmée en l'absence de trouble du rythme ventriculaire soutenu spontané documenté. Arch Mal Cœur 1999; 92: 1311-7.
21. Mittal S, Hao S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB. Significance of ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol 2001; 38: 371-6.
22. Link MS, Kim KMS, Homoud MK, Estes III M, Wang PJ. Long-term outcome of patients with syncope associated with coronary artery disease and a non-diagnostic electrophysiologic evaluation. Am J Cardiol 1999; 83: 134-7.
23. Letorier P, Krahn AD, Lein GJ, Yee R, Skanes AC. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. J Am Coll Cardial 2002; 78: 77-9.
24. O'Donnell D, Hamer A, Horricaan M. Delayed neurally mediated syncope after inferior wall acute mocardial infarction. Am J Cardiol 1999; 90: 157-9.
25. Alboni P, Brignole M, Menozzi C et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 2001; 37: 1921-9.
26. Sheldon R, Rose S, Koshman ML. Isoproterenol tilt-table testing in patients with syncope and structural heart disease. Am J Cardiol 1996; 78: 700-3.
27. Taneja T, Kadissh A, Parker MA, Goldberger JJ. Acute blood pressure effects at the onset of supraventricular and ventricular tachycardia. Am J Cardial 2002; 90: 1294-9.
28. Feldman T, Carroll JD, Munckeck F et al. Hemodynamic recovery during simulated ventricular tachycardia: role of adrenergic receptor activation. Am Heart J 1998; 115: 576-87.
29. Bembilla-Perrot B, Beurrier D, Alsagheer S. Changes in spontoneous sinus node rate after ventricular pacing as an estimate autonomic tone: clinical implications. Eur Heart J 1995; 16: 223-31.